Last updated: June 30, 2026
Choosing how to treat cancer is one of the most consequential decisions a patient and family can face, and understanding treatment results is central to that choice. This article explains how cancer outcomes are measured, what the evidence shows about integrative and alternative approaches, and how to evaluate the success rates clinics report. At EuroMed Foundation in Arizona, the guiding philosophy is integrative care delivered alongside standard treatment, not instead of it.
What Do “Cancer Treatment Results” Actually Mean?
Cancer treatment results refer to measurable outcomes that show how a therapy affects a patient’s disease and well-being. The core metrics include overall survival, 5-year relative survival, response rate, and quality of life. The National Cancer Institute defines overall survival as the length of time from diagnosis or treatment start until death from any cause.
These metrics matter because they let patients compare therapies on a consistent basis rather than relying on anecdotes. Response rate measures tumor shrinkage, survival measures longevity, and quality-of-life captures daily functioning and symptom burden. Together they form a complete picture of whether a treatment is working.
What Is the Difference Between Overall Survival and Relative Survival?
Overall survival measures the time from diagnosis or treatment until death from any cause, while relative survival compares survival among cancer patients to that of the general population. According to NCI SEER data, the 5-year relative survival for all cancers combined reached 70.5% for diagnoses during 2016-2022.
Relative survival isolates the effect of cancer by accounting for deaths from other causes, making it useful for population statistics. Overall survival, by contrast, is widely regarded as the most meaningful clinical endpoint. As NCI and FDA methodologists writing in the Journal of Clinical Oncology state, “Prolongation of overall survival (OS) is generally the most relevant measure of clinical benefit in a randomized clinical trial of an experimental treatment.”
Why Is Quality of Life Considered a Treatment Result?
Quality of life is a legitimate, measurable treatment result because symptom control and patient-reported outcomes can directly affect survival. In a randomized trial published in JAMA, patients whose symptoms were systematically monitored lived longer than those receiving usual care, demonstrating that attention to well-being is not separate from clinical benefit.
That trial, led by Ethan Basch and colleagues, found median overall survival of 31.2 months in the symptom-monitoring group versus 26.0 months in usual care among 766 metastatic cancer patients, a 5-month difference (P=.03). Tracking how patients actually feel enables earlier intervention, fewer complications, and measurable survival gains.
How Have Cancer Survival Rates Changed Over Time?
Cancer survival rates have improved substantially over the past five decades. According to Siegel and colleagues in Cancer Statistics, 2025, 5-year relative survival for all cancers combined rose from 49% in the mid-1970s to 69% for people diagnosed during 2014-2020, reflecting decades of progress in detection and treatment.
That same report estimates nearly 4.5 million cancer deaths have been averted since 1991, driven by earlier detection, reduced smoking, and better therapies. For 2025, researchers project 2,041,910 new cancer cases and 618,120 cancer deaths in the United States. While the disease remains serious, the long-term trajectory offers genuine, evidence-based reason for hope.
Do Holistic or Alternative Cancer Treatments Work Better Than Standard Care?
No. Alternative treatments used instead of standard care are associated with worse outcomes, not better ones. A 2018 study in JAMA Oncology found that patients who chose alternative medicine alone for curable cancers had roughly a two-fold increased risk of death. The critical distinction is between integrative care used with standard treatment and alternative care used in its place.
This distinction is frequently blurred in online discussions and marketing. Integrative care can genuinely improve comfort and quality of life when combined with proven therapies. Substituting unproven therapies for surgery, chemotherapy, radiation, or immunotherapy, however, removes the treatments most likely to control or cure the disease.
What Is the Difference Between Integrative and Alternative Cancer Treatment?
Integrative oncology uses evidence-based complementary therapies alongside standard cancer treatment, while alternative treatment replaces standard care with unproven therapies. This distinction is fundamental: integrative care adds support to conventional medicine, whereas alternative care abandons it. Witt and colleagues, writing for the Society for Integrative Oncology in 2017, define integrative oncology around this evidence-based, additive model.
The table below clarifies the key differences patients should understand.
| Attribute | Integrative Oncology | Alternative Treatment |
|---|---|---|
| Relationship to standard care | Used alongside | Used instead of |
| Evidence base | Evidence-based complementary therapies | Often unproven |
| Primary goal | Support symptoms and quality of life | Replace conventional therapy |
| Effect on survival | Neutral to supportive | Associated with higher mortality |
What Does Research Say About Integrative Oncology Outcomes?
Research indicates that evidence-based integrative oncology can support symptom management and quality of life when combined with standard treatment. Witt and colleagues reported in CA: A Cancer Journal for Clinicians that up to 80% of cancer patients use some form of complementary medicine, underscoring the need for safe, evidence-based integration guided by clinicians.
Because so many patients already use complementary approaches, structured integration matters. Supervised integrative care helps manage nausea, fatigue, pain, anxiety, and sleep disturbances while ensuring therapies do not interfere with chemotherapy or radiation. The evidence supports these approaches for supportive benefit, not as substitutes for disease-directed treatment.
What Are the Risks of Choosing Alternative Treatment Instead of Standard Care?
Substituting alternative treatment for standard care is linked to higher mortality and earlier death. The 2018 JAMA Oncology study by Johnson and colleagues found that patients with non-metastatic breast, prostate, lung, or colorectal cancer who used alternative medicine instead of conventional treatment faced roughly a two-fold increased risk of death compared to those who received standard care.
The danger lies in delay and omission. Curable cancers can become incurable when proven therapies are postponed in favor of unproven ones. As Lorenzo Cohen, PhD, Professor and Director of the Integrative Medicine Program at The University of Texas MD Anderson Cancer Center and a founding member of the Society for Integrative Oncology, states: “Alternative medicine should never be used as a replacement for conventional cancer treatment. When patients forgo recommended therapies in favor of unproven alternatives, studies show they are more likely to die from their disease.”
Can Complementary Therapies Like CBD Improve Treatment Results?
Complementary therapies such as CBD may help with symptom relief and quality of life, but evidence that they improve tumor response or survival is limited. Research synthesized in the Journal of Medical Internet Research confirms sustained public interest in CBD for cancer symptom management, yet rigorous data on direct effects on cancer outcomes remain insufficient.
Patients interested in CBD or similar therapies should use them alongside standard care and disclose all supplements to their oncology team. Some complementary products can interact with chemotherapy or other medications, so clinician oversight is essential to ensure safety and avoid undermining proven treatments.
How Can You Evaluate a Cancer Clinic’s Reported Success Rates?
Evaluate a clinic’s reported success rates by checking for clearly defined endpoints, peer-reviewed or registry-linked data, transparent follow-up periods, and benchmarking against standard-of-care outcomes. A 2023 analysis from the Harvard Kennedy School Misinformation Review, which examined 20,035 cancer-related keywords, documented how patients are frequently exposed to outcome claims that lack rigorous evidence.
Credible outcome reporting names its metrics, such as overall survival or 5-year relative survival, and identifies its data source. Vague phrases like “high success rate” without numbers, denominators, or follow-up duration are warning signs. Trustworthy centers compare their results against established benchmarks rather than presenting figures in isolation.
Why Are Online Ads From Alternative Clinics Often Misleading?
Online ads from alternative clinics are often misleading because advertising platforms allow targeting of patients searching sensitive cancer queries, exposing them to outcome claims unsupported by evidence. The Harvard Kennedy School Misinformation Review documented this targeting, and a 2024 commentary in The Conversation warned that the advertising ecosystem can spread harmful cancer-related misinformation.
The clearest distinction is between testimonial-based and data-based claims. A single patient’s story is emotionally compelling but proves nothing about typical results. Data-based claims cite measurable endpoints, sample sizes, and follow-up periods. Patients should treat personal anecdotes as inspiration to investigate further, never as evidence of effectiveness.
What Questions Should You Ask About Treatment Outcomes?
Asking the right questions helps patients distinguish credible care from marketing. The following questions clarify how a center measures and reports its treatment results.
- What specific survival or outcome metrics do you report, and what is the data source?
- Are your therapies used alongside standard care or instead of it?
- How long do you follow patients after treatment to measure results?
- How do your outcomes compare to standard-of-care benchmarks?
- Is your outcome data peer-reviewed, registry-linked, or independently verified?
- What are the known risks and limitations of the therapies you offer?
How Does EuroMed Foundation Approach Integrative Cancer Treatment Results?
EuroMed Foundation, a holistic cancer treatment center in Arizona, approaches care through an evidence-based integrative model in which complementary therapies are used alongside standard cancer treatment. The emphasis is on transparency, quality-of-life support, and alignment with Society for Integrative Oncology principles, focusing on responsible, patient-centered care rather than unsupported outcome promises.
This means complementary therapies are offered to support symptom management and well-being while patients continue with conventionally recommended treatments. The center’s approach reflects the broader shift toward measuring what matters to patients, as explored in EuroMed’s resource on how patient-reported outcomes are transforming holistic cancer care. Patients and families are welcome to reach out to discuss how integrative support may fit within an evidence-based treatment plan.
Frequently Asked Questions About Cancer Treatment Results
The questions below mirror what patients and families most commonly search when comparing treatment outcomes. Each answer leads with a direct, evidence-based statement.
What Is a Good 5-Year Survival Rate for Cancer?
The 5-year relative survival rate for all cancers combined is 70.5% for diagnoses during 2016-2022, according to NCI SEER data. However, “good” varies widely by cancer type and stage. Some cancers detected early exceed 90% relative survival, while advanced or aggressive cancers fall well below the overall average.
Is It Safe to Refuse Chemotherapy and Use Only Natural Treatments?
Refusing standard care in favor of natural treatments alone is associated with roughly double the risk of death. The 2018 JAMA Oncology study by Johnson and colleagues documented this for curable breast, prostate, lung, and colorectal cancers. As Lorenzo Cohen, PhD, of MD Anderson cautions, unproven alternatives should never replace recommended conventional therapy.
Can Integrative Oncology Improve Quality of Life During Treatment?
Yes. Evidence-based integrative approaches and structured symptom monitoring can improve quality of life and, in some trials, survival. Basch and colleagues found that patient-reported symptom monitoring extended median overall survival by 5 months, and Witt and colleagues affirm that integrative oncology supports well-being when delivered alongside standard care.
How Do I Choose a Trustworthy Cancer Treatment Center?
Choose a center that reports transparent outcome data, integrates evidence-based therapies alongside standard care, and employs credentialed multidisciplinary teams. Look for clearly defined survival metrics, identifiable data sources, and honest discussion of risks. Be cautious of centers relying on testimonials rather than measurable, benchmarked results.
What Should Patients Remember When Comparing Treatment Results?
Patients comparing treatment results should remember four evidence-based points: cancer survival rates have improved substantially over five decades; integrative care works best alongside standard treatment; alternative-only care is associated with roughly double the risk of death; and clinic claims should be evaluated critically using defined metrics and credible data sources.
Cancer outcomes have moved in a hopeful direction, with 5-year relative survival rising from 49% in the mid-1970s to roughly 70% today. The strongest path combines proven, disease-directed treatment with evidence-based supportive care. As patients and families review treatment plans this summer of 2026, the most reliable next step is consulting a qualified oncology team and, where helpful, exploring responsible integrative support such as the care offered at EuroMed Foundation in Arizona.
Frequently Asked Questions
What is a good 5-year survival rate for cancer?
The 5-year relative survival rate for all cancers combined is 70.5% for diagnoses during 2016-2022, according to NCI SEER data. However, what counts as good varies widely by cancer type and stage. Some cancers detected early exceed 90% relative survival, while advanced or aggressive cancers fall well below the overall average.
Is it safe to refuse chemotherapy and use only natural treatments?
Refusing standard care in favor of natural treatments alone is associated with roughly double the risk of death. A 2018 JAMA Oncology study documented this for curable breast, prostate, lung, and colorectal cancers. Curable cancers can become incurable when proven therapies are delayed, so unproven alternatives should never replace recommended conventional treatment.
What is the difference between integrative and alternative cancer treatment?
Integrative oncology uses evidence-based complementary therapies alongside standard cancer treatment, while alternative treatment replaces standard care with unproven therapies. Integrative care adds support to conventional medicine to manage symptoms and quality of life. Alternative care abandons proven therapies entirely and is associated with higher mortality, making this distinction critical for patient safety.
How long do clinics follow patients to measure treatment results?
Credible centers report transparent follow-up periods tied to defined endpoints like 5-year relative survival, which tracks patients for five years after diagnosis. Vague claims of high success rates without a stated follow-up duration, denominator, or data source are warning signs. Always ask how long a center monitors patients after treatment to verify results.
Can integrative oncology improve quality of life during treatment?
Yes. Evidence-based integrative approaches and structured symptom monitoring can improve quality of life and, in some trials, survival. A randomized trial by Basch and colleagues found patient-reported symptom monitoring extended median overall survival by 5 months (31.2 versus 26.0 months). Integrative care supports well-being when delivered alongside standard treatment.
Can complementary therapies like CBD improve cancer treatment results?
Complementary therapies such as CBD may help with symptom relief and quality of life, but evidence that they improve tumor response or survival is limited. Patients should use them alongside standard care and disclose all supplements to their oncology team, since some products can interact with chemotherapy or other medications and require clinician oversight.
How do I choose a trustworthy cancer treatment center?
Choose a center that reports transparent outcome data, integrates evidence-based therapies alongside standard care, and employs credentialed multidisciplinary teams. Look for clearly defined survival metrics, identifiable data sources, and honest discussion of risks. Be cautious of centers relying on testimonials rather than measurable, benchmarked results compared against standard-of-care outcomes.